DSPE-PEG5000-K237 is a PEG compound composed of DSPE and the KDR-targeting peptide (K237). K237 effectively disrupts the interaction between VEGF and KDR receptors, yielding significant biological effects, such as inhibiting angiogenesis and tumor growth. DSPE-PEG5000-K237 is applicable for drug delivery.
Target:
Liposome
* VAT and and shipping costs not included. Errors and price changes excepted